HomeScienceBiology (continued)What is Induced Pluripotent Stem Cell (iPSC)?
Science·2 min·Updated Mar 14, 2026

What is Induced Pluripotent Stem Cell (iPSC)?

Induced Pluripotent Stem Cell

Quick Answer

An Induced Pluripotent Stem Cell (iPSC) is a type of stem cell created in the lab by reprogramming adult cells to an embryonic-like state. This allows them to develop into any cell type in the body, making them valuable for research and potential therapies.

Overview

Induced Pluripotent Stem Cells (iPSCs) are a groundbreaking development in biology that allows scientists to transform ordinary adult cells into cells that can become any type of cell in the body. This is achieved through a process called reprogramming, where specific genes are introduced into the adult cells, effectively resetting them to a more versatile state. iPSCs share many characteristics with embryonic stem cells, which are known for their ability to differentiate into various cell types, making them a powerful tool for medical research. The process of creating iPSCs involves taking a sample of adult cells, such as skin cells, and treating them with factors that induce pluripotency. Once reprogrammed, these cells can be grown in the lab and directed to develop into specific cell types, such as neurons or heart cells. This ability to generate specific cells from a patient’s own tissues holds great promise for personalized medicine, where treatments can be tailored to the individual’s unique biology. The significance of iPSCs extends beyond just research; they have the potential to revolutionize regenerative medicine. For example, researchers are exploring how to use iPSCs to create new heart cells for patients with heart disease. This could lead to innovative treatments that repair damaged tissues and restore function, ultimately improving patient outcomes and reducing the need for organ transplants.


Frequently Asked Questions

iPSCs are derived from adult cells that have been reprogrammed, while embryonic stem cells come from early-stage embryos. Both types of cells can develop into any cell type, but iPSCs provide an ethical alternative to using embryos for research and therapy.
iPSCs can be used in drug development, disease modeling, and regenerative medicine. They offer the potential to create patient-specific cells for testing treatments or even repairing damaged tissues in conditions like heart disease or diabetes.
While iPSCs hold great promise, there are risks involved, including the potential for uncontrolled cell growth or tumor formation. Researchers are actively studying these risks to ensure that iPSCs can be used safely in clinical applications.